Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis

Neurodegenerative Diseases

Volumn 9, Issue 3, 2012, Pages 107-120

  Knippenberg, Sarah ^a,b   Thau, Nadine ^a,b   Schwabe, Kerstin ^a   Dengler, Reinhard ^a,b   Schambach, Axel ^a   Hass, Ralf ^a   Petri, Susanne ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Human umbilical cord blood cell transplantation; Transgenic mouse model

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CILIARY NEUROTROPHIC FACTOR; NEURITE PROMOTING FACTOR; SOMATOMEDIN C; VASCULOTROPIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BODY WEIGHT; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRASPINAL DRUG ADMINISTRATION; LOCOMOTION; LUMBAR SPINAL CORD; MALE; MOTONEURON; MOTOR PERFORMANCE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; ROTAROD TEST; SEX DIFFERENCE; SPINAL CORD VENTRAL HORN; SURVIVAL RATE; TRANSGENIC MOUSE; TREATMENT RESPONSE; UMBILICAL CORD BLOOD; WESTERN BLOTTING;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; FETAL BLOOD; GLIOSIS; HUMANS; INJECTIONS, SPINAL; MALE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MOTOR NEURONS; SPINAL CORD; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME;

EID: 84859004210     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000331327     Document Type: Article

References (39)

1. Kunst CB: Complex genetics of amyotrophic lateral sclerosis. Am J Hum Genet 2004; 75: 933-947. (Pubitemid 39532065)
2. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, ORegan JP, Deng HX, et al: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62. (Pubitemid 23087289)
3. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al: Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994; 264: 1772-1775. (Pubitemid 24227760)
4. Bensimon G, Lacomblez L, Meininger V: A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994; 330: 585-591. (Pubitemid 24065791)
5. Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, Rule M, McMahon AP, Doucette W, Siwek D, Ferrante RJ, Brown RH Jr, Julien JP, Goldstein LS, Cleveland DW: Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003; 302: 113-117. (Pubitemid 37210700)
6. Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K: Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 2007; 10: 608-614. (Pubitemid 46652442)
7. Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S: Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 2007; 10: 615-622. (Pubitemid 46652435)
8. Miller TM, Cleveland DW: Has gene therapy for als arrived? Nat Med 2003; 9: 1256-1257. (Pubitemid 37279841)
9. Xu L, Yan J, Chen D, Welsh AM, Hazel T, Johe K, Hatfield G, Koliatsos VE: Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation 2006; 82: 865-875. (Pubitemid 44564030)
10. Willing AE, Garbuzova-Davis S, Saporta S, Milliken M, Cahill DW, Sanberg PR: hNT neurons delay onset of motor deficits in a model of amyotrophic lateral sclerosis. Brain Res Bull 2001; 56: 525-530. (Pubitemid 34098802)
11. Lepore AC, Rauck B, Dejea C, Pardo AC, Rao MS, Rothstein JD, Maragakis NJ: Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 2008; 11: 1294-1301.
12. Silani V, Cova L, Corbo M, Ciammola A, Polli E: Stem-cell therapy for amyotrophic lateral sclerosis. Lancet 2004; 364: 200-202. (Pubitemid 38891692)
13. Garbuzova-Davis S, Sanberg CD, Kuzmin-Nichols N, Willing AE, Gemma C, Bickford PC, Miller C, Rossi R, Sanberg PR: Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS ONE 2008; 3:e2494.
14. Habisch HJ, Janowski M, Binder D, Kuzma-Kozakiewicz M, Widmann A, Habich A, Schwalenstocker B, Hermann A, Brenner R, Lukomska B, Domanska-Janik K, Ludolph AC, Storch A: Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm 2007; 114: 1395-1406. (Pubitemid 350112275)
15. Vercelli A, Mereuta OM, Garbossa D, Muraca G, Mareschi K, Rustichelli D, Ferrero I, Mazzini L, Madon E, Fagioli F: Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2008; 31: 395-405.
16. Cabanes C, Bonilla S, Tabares L, Martinez S: Neuroprotective effect of adult hematopoietic stem cells in a mouse model of motoneuron degeneration. Neurobiol Dis 2007; 26: 408-418. (Pubitemid 46562571)
17. Schambach A, Galla M, Modlich U, Will E, Chandra S, Reeves L, Colbert M, Williams DA, von Kalle C, Baum C: Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research. Exp Hematol 2006; 34: 588-592.
18. Knippenberg S, Thau N, Dengler R, Petri S: Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS). Behav Brain Res 2010; 213: 82-87.
19. Klapdor K, Dulfer BG, Hammann A, Van der Staay FJ: A low-cost method to analyse footprint patterns. J Neurosci Methods 1997; 75: 49-54. (Pubitemid 27314526)
20. Chen L, Lund PK, Burgess SB, Rudisch BE, McIlwain DL: Growth hormone, insulin-like growth factor I, and motoneuron size. J Neurobiol 1997; 32: 202-212. (Pubitemid 27057515)
21. Suzuki M, McHugh J, Tork C, Shelley B, Klein SM, Aebischer P, Svendsen CN: GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS ONE 2007; 2:e689.
22. Kosta V, Kojundzic SL, Sapunar LC, Sapunar D: The extent of laminectomy affects painrelated behavior in a rat model of neuropathic pain. Eur J Pain 2009; 13: 243-248.
23. Coyne TM, Marcus AJ, Woodbury D, Black IB: Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells 2006; 24: 2483-2492. (Pubitemid 44674309)
24. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M: Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001; 32: 2682-2688. (Pubitemid 33055324)
25. Sanchez-Ramos JR: Neural cells derived from adult bone marrow and umbilical cord blood. J Neurosci Res 2002; 69: 880-893. (Pubitemid 34984705)
26. Dasari VR, Spomar DG, Gondi CS, Sloffer CA, Saving KL, Gujrati M, Rao JS, Dinh DH: Axonal remyelination by cord blood stem cells after spinal cord injury. J Neurotrauma 2007; 24: 391-410. (Pubitemid 46492159)
27. Lee MW, Moon YJ, Yang MS, Kim SK, Jang IK, Eom YW, Park JS, Kim HC, Song KY, Park SC, Lim HS, Kim YJ: Neural differentiation of novel multipotent progenitor cells from cryopreserved human umbilical cord blood. Biochem Biophys Res Commun 2007; 358: 637-643. (Pubitemid 46755752)
28. Morita E, Watanabe Y, Ishimoto M, Nakano T, Kitayama M, Yasui K, Fukada Y, Doi K, Karunaratne A, Murrell WG, Sutharsan R, Mackay-Sim A, Hata Y, Nakashima K: A novel cell transplantation protocol and its application to an ALS mouse model. Exp Neurol 2008; 213: 431-438.
29. Suzuki M, Tork C, Shelley B, McHugh J, Wallace K, Klein SM, Lindstrom MJ, Svendsen CN: Sexual dimorphism in disease onset and progression of a rat model of ALS. Amyotroph Lateral Scler 2007; 8: 20-25. (Pubitemid 46322935)
30. Kirkinezos IG, Hernandez D, Bradley WG, Moraes CT: Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol 2003; 53: 804-807. (Pubitemid 36622520)
31. Choi CI, Lee YD, Gwag BJ, Cho SI, Kim SS, Suh-Kim H: Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice. J Neurol Sci 2008; 268: 40-47. (Pubitemid 351389466)
32. Nakamizo T, Urushitani M, Inoue R, Shinohara A, Sawada H, Honda K, Kihara T, Akaike A, Shimohama S: Protection of cultured spinal motor neurons by estradiol. Neuroreport 2000; 11: 3493-3497.
33. Pehar M, Vargas MR, Cassina P, Barbeito AG, Beckman JS, Barbeito L: Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis. Neurodegenerative Dis 2005; 2: 139-146. (Pubitemid 43827915)
34. Hall ED, Oostveen JA, Gurney ME: Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 1998; 23: 249-256. (Pubitemid 28259722)
35. Nayak MS, Kim YS, Goldman M, Keirstead HS, Kerr DA: Cellular therapies in motor neuron diseases. Biochim Biophys Acta 2006; 1762: 1128-1138. (Pubitemid 44794369)
36. Kalmar B, Greensmith L: Activation of the heat shock response in a primary cellular model of motoneuron neurodegeneration -Evidence for neuroprotective and neurotoxic effects. Cell Mol Biol Lett 2009; 14: 319-335.
37. Kalmar B, Novoselov S, Gray A, Cheetham ME, Margulis B, Greensmith L: Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1 mouse model of ALS. J Neurochem 2008; 107: 339-350.
38. Gifondorwa DJ, Robinson MB, Hayes CD, Taylor AR, Prevette DM, Oppenheim RW, Caress J, Milligan CE: Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J Neurosci 2007; 27: 13173-13180. (Pubitemid 350220502)
39. Chen CT, Foo NH, Liu WS, Chen SH: Infusion of human umbilical cord blood cells ameliorates hind limb dysfunction in experimental spinal cord injury through anti-inflammatory, vasculogenic and neurotrophic mechanisms. Pediatr Neonatol 2008; 49: 77-83.